Ramucirumab FDA approval date

The FDA approved Ramucirumab (Cyramza) on 21 Apr 2014.

FDA approval date
21 Apr 2014

Drug identity checked against registry records

Also recorded as Cyramza

Included trials

TrialSponsorPhaseStatusPrimary completion
A Study of Evorpacept (ALX148) in Patients With Advanced HER2+ Gastric Cancer (ASPEN-06)NCT05002127ALX Oncology Inc.Phase 2, Phase 3Completed2024-05-24Actual

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2014-04-21DayRamucirumabFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "BLA125477", "applicant_as_listed_by_fda": "ELI LILLY AND CO", "brand_names": ["CYRAMZA"], "active_ingredients": ["RAMUCIRUMAB"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20140421", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026